Esophageal cancer has just been diagnosed as lymph node metastasis. At present, there is metastasis of supraclavicular lymph nodes, and other tests have been done. I know I can live longer.

Patients with esophageal cancer, especially upper esophageal cancer, are prone to supraclavicular lymph node metastasis, and middle and lower esophageal cancer can also occur supraclavicular lymph node metastasis, suggesting that the patient's condition has reached the advanced stage. In the past, it was listed as one of the contraindications for esophageal cancer surgery.

In the past two decades, with the improvement of surgical methods and the development of radiotherapy technology for esophageal cancer patients, especially in the last five years, with the research of evidence-based medicine, the postoperative survival rate of esophageal cancer patients has been greatly improved, and there is a new view on the surgical treatment of esophageal cancer patients with supraclavicular lymph node metastasis. Supraclavicular lymph node metastasis is not necessarily a contraindication for surgery.

Clinical research found that:

First, when the focus of primary esophageal cancer can be resected and supraclavicular lymph nodes can be resected, primary esophageal cancer resection and cervical lymph node dissection can be performed at the same time. Postoperative radiotherapy and chemotherapy were supplemented according to the patient's condition.

Second, the focus of primary esophageal cancer can be resected, supraclavicular lymph nodes can be resected, and radiotherapy and chemotherapy can be combined, and then primary esophageal cancer resection and cervical lymph node dissection can be performed. Postoperative radiotherapy and chemotherapy were supplemented.

Through the above standardized treatment, good results can be achieved.

Third, if supraclavicular lymph nodes cannot be removed, surgical treatment is not recommended.